Cargando…
Surgical treatment of large pheochromocytoma (>6 cm): A 10-year single-center experience
OBJECTIVE: Clinical practice guidelines recommend open adrenalectomy (OA) for large pheochromocytoma (LPCC) > 6 cm in size. Although laparoscopic adrenalectomy (LA) for the treatment of LPCC has been reported, its role remains unclear. This study aimed to compare the effectiveness of LA and OA, a...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Second Military Medical University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399532/ https://www.ncbi.nlm.nih.gov/pubmed/36035344 http://dx.doi.org/10.1016/j.ajur.2022.04.004 |
_version_ | 1784772543929909248 |
---|---|
author | Zhang, Liang Chen, Danlei Pang, Yingxian Guan, Xiao Xu, Xiaowen Wang, Cikui Xiao, Qiao Liu, Longfei |
author_facet | Zhang, Liang Chen, Danlei Pang, Yingxian Guan, Xiao Xu, Xiaowen Wang, Cikui Xiao, Qiao Liu, Longfei |
author_sort | Zhang, Liang |
collection | PubMed |
description | OBJECTIVE: Clinical practice guidelines recommend open adrenalectomy (OA) for large pheochromocytoma (LPCC) > 6 cm in size. Although laparoscopic adrenalectomy (LA) for the treatment of LPCC has been reported, its role remains unclear. This study aimed to compare the effectiveness of LA and OA, and summary the surgical treatment experience. METHODS: Data concerning LPCC, from January 2010 to June 2019 of a single institution, were retrospectively reviewed. Altogether 82 patients with a tumor larger than 6 cm were included (52 patients in LA group and 30 patients in OA group). Groups were balanced by propensity score matching (PSM) into 15 pairs. Patients’ demographics, preoperative characteristics, and prognosis were analyzed. RESULTS: Before PSM, the OA group had larger tumor sizes (median [interquartile range, IQR]: 8.9 [7.3–10.3] vs. 7.2 [6.7–8.0] cm; p=0.000) and higher vanillylmandelic acid level (median [IQR]: 114.3 [67.8–326.4] vs. 66.6 [37.8–145.8] μmol/24 h; p =0.004) and needed a higher cumulative dose of prazosin (median [IQR]: 83.5 [37.0–154.0] vs. 38.0 [21.0–81.0] mg; p=0.028). After PSM, the baseline data showed no significant differences between both groups. The LA group had relatively more stable blood pressure in surgery, with a lower fluctuation of systolic blood pressure (mean±standard deviation [SD]: 70.9±25.1 vs. 107.4±46.2 mmHg, p=0.012) and a lower percentage of hemodynamic instability (46.7% vs. 86.7%, p=0.020). The LA group had shorter postoperative hospital stays (mean±SD: 6.4±2.7 vs. 10.1±3.4 days; p=0.003) than the OA group. Differences regarding metastasis rate (6.7% vs. 0, p=1.000) were not statistically significant between LA and OA groups. The median (IQR) follow-up time of 82 patients was 72.5 (47.0–103.5) months. Binary logistic regression showed that right-side tumors or those >8 cm in size were independent risk factors of OA. CONCLUSION: LA is a safe, minimally invasive procedure for LPCC and has relatively better perioperative characteristics in large medical centers. Patients with tumors on the right side or larger than 8 cm are more likely to undergo OA initially. |
format | Online Article Text |
id | pubmed-9399532 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Second Military Medical University |
record_format | MEDLINE/PubMed |
spelling | pubmed-93995322022-08-26 Surgical treatment of large pheochromocytoma (>6 cm): A 10-year single-center experience Zhang, Liang Chen, Danlei Pang, Yingxian Guan, Xiao Xu, Xiaowen Wang, Cikui Xiao, Qiao Liu, Longfei Asian J Urol Original Article OBJECTIVE: Clinical practice guidelines recommend open adrenalectomy (OA) for large pheochromocytoma (LPCC) > 6 cm in size. Although laparoscopic adrenalectomy (LA) for the treatment of LPCC has been reported, its role remains unclear. This study aimed to compare the effectiveness of LA and OA, and summary the surgical treatment experience. METHODS: Data concerning LPCC, from January 2010 to June 2019 of a single institution, were retrospectively reviewed. Altogether 82 patients with a tumor larger than 6 cm were included (52 patients in LA group and 30 patients in OA group). Groups were balanced by propensity score matching (PSM) into 15 pairs. Patients’ demographics, preoperative characteristics, and prognosis were analyzed. RESULTS: Before PSM, the OA group had larger tumor sizes (median [interquartile range, IQR]: 8.9 [7.3–10.3] vs. 7.2 [6.7–8.0] cm; p=0.000) and higher vanillylmandelic acid level (median [IQR]: 114.3 [67.8–326.4] vs. 66.6 [37.8–145.8] μmol/24 h; p =0.004) and needed a higher cumulative dose of prazosin (median [IQR]: 83.5 [37.0–154.0] vs. 38.0 [21.0–81.0] mg; p=0.028). After PSM, the baseline data showed no significant differences between both groups. The LA group had relatively more stable blood pressure in surgery, with a lower fluctuation of systolic blood pressure (mean±standard deviation [SD]: 70.9±25.1 vs. 107.4±46.2 mmHg, p=0.012) and a lower percentage of hemodynamic instability (46.7% vs. 86.7%, p=0.020). The LA group had shorter postoperative hospital stays (mean±SD: 6.4±2.7 vs. 10.1±3.4 days; p=0.003) than the OA group. Differences regarding metastasis rate (6.7% vs. 0, p=1.000) were not statistically significant between LA and OA groups. The median (IQR) follow-up time of 82 patients was 72.5 (47.0–103.5) months. Binary logistic regression showed that right-side tumors or those >8 cm in size were independent risk factors of OA. CONCLUSION: LA is a safe, minimally invasive procedure for LPCC and has relatively better perioperative characteristics in large medical centers. Patients with tumors on the right side or larger than 8 cm are more likely to undergo OA initially. Second Military Medical University 2022-07 2022-06-20 /pmc/articles/PMC9399532/ /pubmed/36035344 http://dx.doi.org/10.1016/j.ajur.2022.04.004 Text en © 2022 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Zhang, Liang Chen, Danlei Pang, Yingxian Guan, Xiao Xu, Xiaowen Wang, Cikui Xiao, Qiao Liu, Longfei Surgical treatment of large pheochromocytoma (>6 cm): A 10-year single-center experience |
title | Surgical treatment of large pheochromocytoma (>6 cm): A 10-year single-center experience |
title_full | Surgical treatment of large pheochromocytoma (>6 cm): A 10-year single-center experience |
title_fullStr | Surgical treatment of large pheochromocytoma (>6 cm): A 10-year single-center experience |
title_full_unstemmed | Surgical treatment of large pheochromocytoma (>6 cm): A 10-year single-center experience |
title_short | Surgical treatment of large pheochromocytoma (>6 cm): A 10-year single-center experience |
title_sort | surgical treatment of large pheochromocytoma (>6 cm): a 10-year single-center experience |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399532/ https://www.ncbi.nlm.nih.gov/pubmed/36035344 http://dx.doi.org/10.1016/j.ajur.2022.04.004 |
work_keys_str_mv | AT zhangliang surgicaltreatmentoflargepheochromocytoma6cma10yearsinglecenterexperience AT chendanlei surgicaltreatmentoflargepheochromocytoma6cma10yearsinglecenterexperience AT pangyingxian surgicaltreatmentoflargepheochromocytoma6cma10yearsinglecenterexperience AT guanxiao surgicaltreatmentoflargepheochromocytoma6cma10yearsinglecenterexperience AT xuxiaowen surgicaltreatmentoflargepheochromocytoma6cma10yearsinglecenterexperience AT wangcikui surgicaltreatmentoflargepheochromocytoma6cma10yearsinglecenterexperience AT xiaoqiao surgicaltreatmentoflargepheochromocytoma6cma10yearsinglecenterexperience AT liulongfei surgicaltreatmentoflargepheochromocytoma6cma10yearsinglecenterexperience |